Medical Disposables & Supplies 過去の業績

過去基準チェック /06

Medical Disposables & Suppliesの収益は年間平均-54%の割合で減少していますが、 Healthcare業界の収益は年間増加しています。収益は年間15.7% 11.6%割合で増加しています。

主要情報

-54.0%

収益成長率

-53.2%

EPS成長率

Healthcare 業界の成長	-2.9%
収益成長率	11.6%
株主資本利益率	-38.9%
ネット・マージン	-7.7%
次回の業績アップデート	29 Nov 2024

Recent updates

収支内訳

Medical Disposables & Supplies の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

JMSE:MDS 収益、費用、利益 ( )JMD Millions
日付	収益	収益	G+A経費
30 Sep 24	3,797	-292	867
30 Jun 24	3,756	-286	864
31 Mar 24	3,709	-292	859
31 Dec 23	3,699	-72	827
30 Sep 23	3,739	5	814
30 Jun 23	3,803	54	807
31 Mar 23	3,770	72	787
31 Dec 22	3,686	90	790
30 Sep 22	3,620	82	766
30 Jun 22	3,626	88	745
31 Mar 22	3,416	97	685
31 Dec 21	3,150	122	608
30 Sep 21	2,902	128	558
30 Jun 21	2,595	102	496
31 Mar 21	2,423	70	481
31 Dec 20	2,522	18	473
30 Sep 20	2,499	-1	448
30 Jun 20	2,434	12	438
31 Mar 20	2,481	35	429
31 Dec 19	2,367	87	380
30 Sep 19	2,302	101	375
30 Jun 19	2,238	110	356
31 Mar 19	2,222	113	340
31 Dec 18	2,140	101	320
30 Sep 18	2,123	113	307
30 Jun 18	2,106	113	306
31 Mar 18	2,045	110	299
31 Dec 17	1,942	97	292
30 Sep 17	1,852	95	281
30 Jun 17	1,769	98	266
31 Mar 17	1,714	101	255
31 Dec 16	1,667	96	247
30 Sep 16	1,555	91	233
30 Jun 16	1,462	95	219
31 Mar 16	1,327	96	210
31 Dec 15	1,229	95	205
30 Sep 15	1,218	89	203
30 Jun 15	1,193	87	199
31 Mar 15	1,159	85	188
31 Dec 14	1,096	77	176
30 Sep 14	1,024	71	164
30 Jun 14	966	62	149
31 Mar 14	913	57	135
31 Dec 13	975	69	136

質の高い収益: MDSは現在利益が出ていません。

利益率の向上: MDSは現在利益が出ていません。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: MDSは利益が出ておらず、過去 5 年間で損失は年間54%の割合で増加しています。

成長の加速: MDSの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: MDSは利益が出ていないため、過去 1 年間の収益成長をHealthcare業界 ( 17.9% ) と比較することは困難です。

株主資本利益率

高いROE: MDSは現在利益が出ていないため、自己資本利益率 ( -38.89% ) はマイナスです。

Medical Disposables & Supplies 過去の業績

過去 基準チェック /06

主要情報

最近の業績更新

Second quarter 2025 earnings released: JA$0.16 loss per share (vs JA$0.10 loss in 2Q 2024)

Medical Disposables & Supplies Limited to Report Fiscal Year 2024 Final Results on Nov 29, 2024

Full year 2024 earnings released: JA$1.11 loss per share (vs JA$0.27 profit in FY 2023)

Third quarter 2024 earnings released: JA$0.19 loss per share (vs JA$0.11 profit in 3Q 2023)

Second quarter 2024 earnings released: JA$0.15 loss per share (vs JA$0.07 profit in 2Q 2023)

First quarter 2024 earnings released: JA$0.01 loss per share (vs JA$0.06 profit in 1Q 2023)

Recent updates

Second quarter 2025 earnings released: JA$0.16 loss per share (vs JA$0.10 loss in 2Q 2024)

Medical Disposables & Supplies Limited to Report Fiscal Year 2024 Final Results on Nov 29, 2024

Medical Disposables & Supplies Limited Announces Board Appointments

Full year 2024 earnings released: JA$1.11 loss per share (vs JA$0.27 profit in FY 2023)

New minor risk - Share price stability

Sandra Glasgow Tenders Her Resignation from the Board of Directors of Medical Disposables & Supplies Limited

Third quarter 2024 earnings released: JA$0.19 loss per share (vs JA$0.11 profit in 3Q 2023)

New major risk - Share price stability

Second quarter 2024 earnings released: JA$0.15 loss per share (vs JA$0.07 profit in 2Q 2023)

Investor sentiment deteriorates as stock falls 24%

First quarter 2024 earnings released: JA$0.01 loss per share (vs JA$0.06 profit in 1Q 2023)

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 17%

Full year 2023 earnings released: EPS: JA$0.27 (vs JA$0.37 in FY 2022)

Investor sentiment improves as stock rises 22%

Third quarter 2023 earnings released: EPS: JA$0.11 (vs JA$0.11 in 3Q 2022)

Investor sentiment improves as stock rises 18%

Investor sentiment improved over the past week

Upcoming dividend of JA$0.09 per share

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Full year 2022 earnings released: EPS: JA$0.37 (vs JA$0.27 in FY 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS JA$0.08 (vs JA$0.02 loss in 2Q 2021)

Second quarter 2022 earnings released: EPS JA$0.08 (vs JA$0.02 loss in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of JA$0.07 per share

First quarter 2022 earnings released: EPS JA$0.10 (vs JA$0.03 loss in 1Q 2021)

Full year 2021 earnings released

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

New 90-day high: JA$4.74

Third quarter 2021 earnings released: EPS JA$0.10 (vs JA$0.02 in 3Q 2020)

Second quarter 2021 earnings released: JA$0.02 loss per share

Market pulls back on stock over the past week

New 90-day low: JA$4.30

New 90-day low - JA$4.67

First quarter earnings released

New 90-day low - JA$5.07

収支内訳

収益と収入の歴史

フリー・キャッシュフローと収益の比較

過去の収益成長分析

株主資本利益率

総資産利益率

使用総資本利益率

過去の好業績企業の発掘

過去基準チェック /06